日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1(+) myeloid cells in hepatocellular carcinoma.

SIRPα阻断疗法通过抑制肝细胞癌中的PD-L1(+)髓系细胞来增强免疫疗法

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07779-7
Huang Da, Xu Min, Wang Hui, Zhao Yufei, Zhang Zihao, Yu Mincheng, Zhou Mingqin, Pan Jingying, Zeng Hong, Yu Zichuan, Yu Qiang, Wu Mengyuan, Xu Wenxin, Zhou Binghai, Zhang Bo, Li Hui, Guo Lei, Xie Peiyi
细胞生物学
发表日期：2025
文献求助 收藏

A Molecular Signature of the Ubiquitin-Proteasome System for Forecasting Prognosis in Thyroid Carcinoma Patients.

泛素-蛋白酶体系统的分子特征可用于预测甲状腺癌患者的预后

期刊:Journal of Inflammation Research
影响因子:4.1
doi:10.2147/JIR.S499820
Zeng Hong, Geng Xitong, Wan Hao, Qu Xiaoyu, Tang Shengwei, Zhang Ruiyu, Zhou Minqin, Yu Zichuan, Pan Jingying, Zheng Hao, Zhu Yanting, Huang Shuhan, Huang Da
肿瘤
甲状腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

An optimized DCO with modified binary-weighted DCTLs based hybrid tuning banks for an E-band DPLL

一种基于改进的二进制加权DCTL的混合调谐库的优化DCO，用于E波段DPLL。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-51510-z
Tang, Lu; Yu, Zichuan; Lu, Yujia; Jin, Zhiqi; Xia, Sicong; Zhang, Youming; Tang, Xusheng
发表日期：2024
文献求助 收藏

LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior

LAMP3是一种与免疫行为相关的强效子宫内膜癌预后生物标志物。

期刊:Aging-Us
影响因子:3.9
doi:10.18632/aging.205414
Fu, Bidong; Zhou, Minqin; Geng, Xitong; Jiang, Yike; Zeng, Hong; Zhou, Xuanrui; Yu, Zichuan; Pan, Jingying; Zhu, Yanting; Zheng, Hao; Huang, Shuhan; Gong, Yiyang; Huang, Da; Zhong, Yanying
免疫/内分泌
子宫内膜癌
肿瘤免疫
肿瘤
发表日期：2024
文献求助 收藏

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification

基于综合计算生物学和实验验证，鉴定出胶质瘤的可靠生物标志物LAPTM4A

期刊:Aging-Us
影响因子:3.9
doi:10.18632/aging.205736
Ding, Yongqi; Jiang, Yike; Zeng, Hong; Zhou, Minqin; Zhou, Xuanrui; Yu, Zichuan; Pan, Jingying; Geng, Xitong; Zhu, Yanting; Zheng, Hao; Huang, Shuhan; Gong, Yiyang; Huang, Huabin; Xiong, Chengfeng; Huang, Da
胶质瘤
发表日期：2024
文献求助 收藏

An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer

与上皮间质转化（EMT）相关的免疫生物标志物可作为膀胱癌预后和药物反应的预测因子。

期刊:Aging-Us
影响因子:3.9
doi:10.18632/aging.205927
Jiang, Yike; Yu, Zichuan; Zheng, Hao; Zhou, Xuanrui; Zhou, Minqin; Geng, Xitong; Zhu, Yanting; Huang, Shuhan; Gong, Yiyang; Guo, Liangyun
肿瘤
肿瘤免疫
膀胱癌
上皮间质转化
免疫/内分泌
发表日期：2024
文献求助 收藏

FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma

FARSB 是一种新型的低甲基化和免疫细胞浸润相关的肝细胞癌预后生物标志物

期刊:Aging-Us
影响因子:3.9
doi:10.18632/aging.204619
Zhen, Jing; Pan, Jingying; Zhou, Xuanrui; Yu, Zichuan; Jiang, Yike; Gong, Yiyang; Ding, Yongqi; Liu, Yue; Guo, Liangyun
细胞生物学
肿瘤
免疫/内分泌
肿瘤免疫
表观遗传
发表日期：2023
文献求助 收藏

Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma

ARHGAP39作为肝细胞癌独立预后生物标志物的生物学功能分析

期刊:Aging-Us
影响因子:3.9
doi:10.18632/aging.204635
Ding, Yongqi; Gong, Yiyang; Zeng, Hong; Zhou, Xuanrui; Yu, Zichuan; Pan, Jingying; Zhou, Minqin; Liu, Shiwen; Lai, Wei
ARH
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity

研究发现RP2是胶质瘤的预后生物标志物，主要通过调节肿瘤免疫促进胶质瘤的发生发展。

期刊:Aging-Us
影响因子:3.9
doi:10.18632/aging.204962
Gong, Yiyang; Ke, Yun; Yu, Zichuan; Pan, Jingying; Zhou, Xuanrui; Jiang, Yike; Zhou, Minqin; Zeng, Hong; Geng, Xitong; Hu, Guowen
胶质瘤
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏

ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle

ZNF320 是一种低甲基化的预后生物标志物，参与肝细胞癌的免疫浸润，并与细胞周期相关。

期刊:Aging-Us
影响因子:3.9
doi:10.18632/aging.204350
Zhen, Jing; Ke, Yun; Pan, Jingying; Zhou, Minqin; Zeng, Hong; Song, Gelin; Yu, Zichuan; Fu, Bidong; Liu, Yue; Huang, Da; Wu, Honghu
表观遗传
免疫/内分泌
肿瘤
细胞生物学
肿瘤免疫
发表日期：2022
文献求助 收藏